OppenheimerFunds’s Nektar Therapeutics NKTR Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$581M	Sell	17,302,891 -34	-0%	-$1.14K	0.72%	27
2018 Q4	$569M	Buy	17,302,925 +5,300,665	+44%	+$174M	0.81%	18
2018 Q3	$732M	Buy	12,002,260 +441,481	+4%	+$26.9M	0.85%	15
2018 Q2	$565M	Buy	11,560,779 +845,257	+8%	+$41.3M	0.67%	23
2018 Q1	$1.14B	Sell	10,715,522 -3,889,047	-27%	-$413M	1.42%	5
2017 Q4	$872M	Sell	14,604,569 -10,167,661	-41%	-$607M	1.05%	8
2017 Q3	$595M	Sell	24,772,230 -484,991	-2%	-$11.6M	0.73%	19
2017 Q2	$494M	Buy	25,257,221 +1,246,403	+5%	+$24.4M	0.61%	30
2017 Q1	$564M	Sell	24,010,818 -997,502	-4%	-$23.4M	0.68%	18
2016 Q4	$307M	Buy	25,008,320 +3,715	+0%	+$45.6K	0.39%	68
2016 Q3	$430M	Sell	25,004,605 -1,000,748	-4%	-$17.2M	0.54%	33
2016 Q2	$370M	Sell	26,005,353 -2,408	-0%	-$34.3K	0.49%	47
2016 Q1	$358M	Buy	26,007,761 +4,386	+0%	+$60.3K	0.47%	51
2015 Q4	$438M	Sell	26,003,375 -396,625	-2%	-$6.68M	0.56%	39
2015 Q3	$289M	Buy	26,400,000 +400,000	+2%	+$4.38M	0.39%	66
2015 Q2	$325M	Hold	26,000,000	–	–	0.37%	65
2015 Q1	$286M	Buy	26,000,000 +1,800,000	+7%	+$19.8M	0.32%	88
2014 Q4	$375M	Sell	24,200,000 -200,000	-0.8%	-$3.1M	0.42%	60
2014 Q3	$295M	Hold	24,400,000	–	–	0.32%	80
2014 Q2	$313M	Hold	24,400,000	–	–	0.35%	72
2014 Q1	$296M	Buy	24,400,000 +1,400,000	+6%	+$17M	0.35%	74
2013 Q4	$261M	Hold	23,000,000	–	–	0.32%	79
2013 Q3	$240M	Buy	23,000,000 +300,000	+1%	+$3.14M	0.32%	86
2013 Q2	$262M	Buy	+22,700,000	New	+$262M	0.38%	61